Explore insights by topic
All insights 5
Article Drug pipeline
From Diabetes to Breast Cancer: Promise, Uncertainty, and the Case for Prospective Trials of GLP-1 Receptor Agonists
GLP-1 receptor agonists have transformed the treatment of type 2 diabetes and obesity. Now, researchers are exploring a new question: Could these medications also play a…
Read the article
Article Drug pipeline
Translating ASCO 2026: What Matters Most for Managed Care
ASCO 2026, the largest oncology conference in the world, featured groundbreaking clinical trial results expected to transform standards of care (SoC) in oncology. For payors, staying…
Read the article
Webinar Drug pipeline
Webinar: Translating ASCO 2026: What Matters Most for Managed Care
Available On-Demand
Watch on demand
Article Drug pipeline
Innovations in Bladder Cancer Therapy: Implications for Managed Care
The treatment landscape for bladder cancer is rapidly evolving. Additional therapeutic options have been recently approved or are in the pipeline for patients in both non-muscle…
Read the article
Article Drug pipeline
Front-Line Covalent BTK Inhibitor + Venetoclax ± Obinutuzumab: A New Triple Threat?
Emerging front-line chronic lymphocytic leukemia (CLL) treatment options combine covalent BTK inhibitors with venetoclax and obinutuzumab, prompting new considerations around clinical benefit, risk, and cost compared…
Read the article